China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SZSE:000999

Watchlist Manager
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Logo
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SZSE:000999
Watchlist
Price: 46.25 CNY 1.36% Market Closed
Market Cap: 59B CNY
Have any thoughts about
China Resources Sanjiu Medical & Pharmaceutical Co Ltd?
Write Note

China Resources Sanjiu Medical & Pharmaceutical Co Ltd
Effect of Foreign Exchange Rates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

China Resources Sanjiu Medical & Pharmaceutical Co Ltd
Effect of Foreign Exchange Rates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SZSE:000999
Effect of Foreign Exchange Rates
-ÂĄ564.6k
CAGR 3-Years
47%
CAGR 5-Years
7%
CAGR 10-Years
1%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Effect of Foreign Exchange Rates
-ÂĄ122.4m
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Effect of Foreign Exchange Rates
ÂĄ5.2m
CAGR 3-Years
N/A
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Effect of Foreign Exchange Rates
-ÂĄ28.4m
CAGR 3-Years
31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Effect of Foreign Exchange Rates
-ÂĄ3m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
-9%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Effect of Foreign Exchange Rates
-ÂĄ2.6m
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

China Resources Sanjiu Medical & Pharmaceutical Co Ltd
Glance View

Market Cap
59.4B CNY
Industry
Pharmaceuticals

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., a leading player in the healthcare sector, has carved a distinguished path through its commitment to innovation and quality. Established in 1992, the company has grown into a comprehensive healthcare provider with a diverse product portfolio that includes traditional Chinese medicine, over-the-counter drugs, and prescription medications. Leveraging its strong distribution network and extensive research and development capabilities, Sanjiu has positioned itself as a trusted brand among consumers and healthcare professionals alike. As the Chinese healthcare market continues to expand, fueled by a growing middle class and increasing health awareness, Sanjiu is well-poised to capitalize on these trends, driving both revenue growth and market share expansion. An investor looking into China Resources Sanjiu will find a company that not only maintains a robust financial foundation but also demonstrates an unwavering focus on sustainable practices and innovation. The company’s strategic partnerships and investments in modern technology, including digital health and telemedicine, further amplify its competitive edge. With a proactive approach to meeting evolving healthcare demands and an eye on regulatory developments, Sanjiu is not just a health-focused enterprise but a forward-thinking entity that embraces change in a dynamic industry. By combining traditional wisdom with modern methodologies, China Resources Sanjiu stands at the intersection of heritage and innovation, offering promising avenues for long-term growth and investor confidence.

Intrinsic Value
60.44 CNY
Undervaluation 23%
Intrinsic Value
Price

See Also

What is China Resources Sanjiu Medical & Pharmaceutical Co Ltd's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
-564.6k CNY

Based on the financial report for Sep 30, 2024, China Resources Sanjiu Medical & Pharmaceutical Co Ltd's Effect of Foreign Exchange Rates amounts to -564.6k CNY.

What is China Resources Sanjiu Medical & Pharmaceutical Co Ltd's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 10Y
1%

The average annual Effect of Foreign Exchange Rates growth rates for China Resources Sanjiu Medical & Pharmaceutical Co Ltd have been 47% over the past three years , 7% over the past five years , and 1% over the past ten years .

Back to Top